ConductScience.org, home

Paper30085331

Exendin‑4 reverses endothelial dysfunction in mice fed a high‑cholesterol diet by a GTP cyclohydrolase‑1/tetrahydrobiopterin pathway.

Tang Z and 5 others. Mol Med Rep, 2018. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Exendin‑4 reverses endothelial dysfunction in mice fed a high‑cholesterol diet by a GTP cyclohydrolase‑1/tetrahydrobiopterin pathway. Papers, record 30085331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30085331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exendin‑4 reverses endothelial dysfunction in mice fed a high‑cholesterol diet by a GTP cyclohydrolase‑1/tetrahydrobiopterin pathway.
PubMed
Journal
Mol Med Rep
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.3
iCite
Revised in PubMed
2025-01-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tang ZZhiqi
2Liu LLijuan
3Guo YYujie
4Deng GGuoxiong
5Chen MMeixiang
6Wei JJinru

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Apolipoproteins EMajor topic
Endothelium, VascularMajor topic
Hypoglycemic AgentsMajor topic
PeptidesMajor topic
VenomsMajor topic
Glucagon-Like Peptide-1 Receptor AgonistsMajor topic
Animals
Arteries
Biopterins
Exenatide
GTP Cyclohydrolase
Mice
Mice, Inbred C57BL
Mice, Inbred Strains
Nitric Oxide
Nitric Oxide Synthase Type III
Vasodilation

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114707037Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.Arterioscler Thromb Vasc Biol2004https://conductscience.org/library/papers/14707037PubMed
226322175Inflammation, oxidative stress and renin angiotensin system in atherosclerosis.World J Biol Chem2015https://conductscience.org/library/papers/26322175PubMed
316946131Tetrahydrobiopterin and cardiovascular disease.Arterioscler Thromb Vasc Biol2006https://conductscience.org/library/papers/16946131PubMed
418708025GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP.Arch Biochem Biophys2008https://conductscience.org/library/papers/18708025PubMed
516179591
Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression.
Circ Res2005https://conductscience.org/library/papers/16179591PubMed
617272747Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice.Arterioscler Thromb Vasc Biol2007https://conductscience.org/library/papers/17272747PubMed
711397713Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice.Arterioscler Thromb Vasc Biol2001https://conductscience.org/library/papers/11397713PubMed
817463333A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression.Arterioscler Thromb Vasc Biol2007https://conductscience.org/library/papers/17463333PubMed
910469573The Akt kinase signals directly to endothelial nitric oxide synthase.Curr Biol1999https://conductscience.org/library/papers/10469573PubMed
107356152Analysis of reduced forms of biopterin in biological tissues and fluids.Anal Biochem1980https://conductscience.org/library/papers/7356152PubMed
1112588755Endothelial dysfunction: a marker of atherosclerotic risk.Arterioscler Thromb Vasc Biol2003https://conductscience.org/library/papers/12588755PubMed
1226338040Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study.Cardiovasc Diabetol2015https://conductscience.org/library/papers/26338040PubMed
1326499181Vascular nitric oxide: Beyond eNOS.J Pharmacol Sci2015https://conductscience.org/library/papers/26499181PubMed
1418427132Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.Circulation2008https://conductscience.org/library/papers/18427132PubMed
156508212Performance of three enzymic methods for filter paper glucose determination.Ann Clin Biochem1984https://conductscience.org/library/papers/6508212PubMed
1618268143Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension.Circulation2008https://conductscience.org/library/papers/18268143PubMed
1712176133GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation.Cardiovasc Res2002https://conductscience.org/library/papers/12176133PubMed
1821167014The cardiovascular effects of GLP-1 receptor agonists.Cardiovasc Ther2012https://conductscience.org/library/papers/21167014PubMed
1923709595Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.Am J Physiol Heart Circ Physiol2013https://conductscience.org/library/papers/23709595PubMed
2026316699Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.Drug Des Devel Ther2015https://conductscience.org/library/papers/26316699PubMed

See all 41 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
38720777Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease.Front Pharmacol2024https://conductscience.org/library/papers/38720777PubMed
36311291Characterization of Ferroptosis-Related Molecular Subtypes with Immune Infiltrations in Neuropathic Pain.J Pain Res2022https://conductscience.org/library/papers/36311291PubMed
36140374Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options.Biomedicines2022https://conductscience.org/library/papers/36140374PubMed
35947249SGLT2 Inhibitors: New Hope for the Treatment of Acute Myocardial Infarction?Am J Cardiovasc Drugs2022https://conductscience.org/library/papers/35947249PubMed
32782412Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.Sci Rep2020https://conductscience.org/library/papers/32782412PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
DPP41803PubTator's text mininghttps://conductscience.org/library/genes/1803NCBI Gene
GCH12643PubTator's text mininghttps://conductscience.org/library/genes/2643NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
NOS34846PubTator's text mininghttps://conductscience.org/library/genes/4846NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30085331

GET https://conductscience.org/api/papers/v1/30085331/references?page=2